Beacon Biosignals
Company · Boston, Massachusetts, USA
Uses machine learning on EEG to create brain-based biomarkers for clinical trials, including at-home sleep monitoring.
Beacon works with drug developers to measure how treatments affect the brain. After acquiring Dreem’s health business, it uses an FDA-cleared headband to collect clinical-grade sleep EEG at home.
In the news
IndustryNon-invasive
Beacon Biosignals buys home sleep testing provider Snap Diagnostics
The EEG company says the deal more than doubles its patient reach and gives it a route to bring EEG-based home sleep tests to patients from 2027.
FundingNon-invasive
Beacon Biosignals raises $86 million to build AI brain biomarkers from home EEG
The Series B backs Beacon's FDA-cleared Waveband headband and a growing neurodiagnostic dataset for drug trials.